Traveling Pharmacy
Fed up with years of FDA foot dragging, relatives of Alzheimer's patients are launching a "buyers' club" to distribute unapproved drugs for the disease. Taking their cue from several dozen buyers' clubs that import large quantities of experimental drugs for sale to AIDS patients, the new club's organizers plan to sell THA, the promising Alzheimer's drug that the FDA has refused to approve. (See "Unequal Treatments," April.)
Although FDA regulations allow patients to import only small amounts of unapproved drugs for personal use, the agency has turned a blind eye to the AIDS buyers' clubs. But the Alzheimer's buyers' club is likely to attract more attention, partly because of the enormous potential market for unapproved Alzheimer's drugs: Between 4 million and 5 million Americans have Alzheimer's. Some 200,000 new cases are diagnosed every year—more than the total number of AIDS cases in the country.
Unlike the AIDS buyers' clubs, which resemble shops, the Alzheimer's buyers' club will be a moving target. Customers will mail their orders to an address outside the United States. Saul Kent, president of the Florida-based Life Extension Foundation, which is helping to promote the club, won't say whether that address will be the point of distribution for the drugs.
"Just let the FDA try to figure that out," he says. "They're going to have a very hard time tracking these people down."
A newsletter, The Caregiver, will advertise the club and provide its foreign mailing address. Like the drug shipments, the newsletter will seem to come out of nowhere, unnumbered and with no return address. Until now, relatives have had to smuggle THA in from abroad at great personal expense and risk.
"These are just ordinary, older, conservative Americans," says Kent. "When you cause people like that to become radical, they become more radical than the young people."
This article originally appeared in print under the headline "Traveling Pharmacy."
Hide Comments (0)
Editor's Note: As of February 29, 2024, commenting privileges on reason.com posts are limited to Reason Plus subscribers. Past commenters are grandfathered in for a temporary period. Subscribe here to preserve your ability to comment. Your Reason Plus subscription also gives you an ad-free version of reason.com, along with full access to the digital edition and archives of Reason magazine. We request that comments be civil and on-topic. We do not moderate or assume any responsibility for comments, which are owned by the readers who post them. Comments do not represent the views of reason.com or Reason Foundation. We reserve the right to delete any comment and ban commenters for any reason at any time. Comments may only be edited within 5 minutes of posting. Report abuses.
Please
to post commentsMute this user?
Ban this user?
Un-ban this user?
Nuke this user?
Un-nuke this user?
Flag this comment?
Un-flag this comment?